These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32202562)

  • 21. A review of the contemporary use of inotropes in patients with heart failure.
    Neicheril R; Snipelisky D
    Curr Opin Cardiol; 2024 Mar; 39(2):104-109. PubMed ID: 38170194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology.
    Gustafsson F; Damman K; Nalbantgil S; Van Laake LW; Tops LF; Thum T; Adamopoulos S; Bonios M; Coats AJ; Crespo-Leiro MG; Mehra MR; Filippatos G; Hill L; Metra M; Jankowska E; de Jonge N; Kaye D; Masetti M; Parissis J; Milicic D; Seferovic P; Rosano G; Ben Gal T
    Eur J Heart Fail; 2023 Apr; 25(4):457-468. PubMed ID: 36847113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure.
    Baras Shreibati J; Goldhaber-Fiebert JD; Banerjee D; Owens DK; Hlatky MA
    JACC Heart Fail; 2017 Feb; 5(2):110-119. PubMed ID: 28017351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced heart failure: an appraisal of the potential of levosimendan in this end-stage scenario and some related ethical considerations.
    Fruhwald S; Pollesello P; Fruhwald F
    Expert Rev Cardiovasc Ther; 2016 Dec; 14(12):1335-1347. PubMed ID: 27778514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Home Inotropes and Other Palliative Care.
    Ginwalla M
    Heart Fail Clin; 2016 Jul; 12(3):437-48. PubMed ID: 27371519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End-of-life options for patients with advanced heart failure.
    Goldfinger JZ; Adler ED
    Curr Heart Fail Rep; 2010 Sep; 7(3):140-7. PubMed ID: 20585999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Status of Inotropes in Heart Failure.
    Ginwalla M; Tofovic DS
    Heart Fail Clin; 2018 Oct; 14(4):601-616. PubMed ID: 30266368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous Intravenous Inotropic Support for Advanced Heart Failure: Palliative Considerations.
    McPherson A; Nguyen C; Groninger H; Anderson KM; Henderson P; Rao A
    J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):59-67. PubMed ID: 35319327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palliative Care in Heart Failure.
    Ghashghaei R; Yousefzai R; Adler E
    Prog Cardiovasc Dis; 2016; 58(4):455-60. PubMed ID: 26773596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantation.
    Thompson KA; Philip KJ; Simsir S; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):231-43. PubMed ID: 20595625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced Heart Failure Management and Transplantation.
    Levine A; Gupta CA; Gass A
    Cardiol Clin; 2019 Feb; 37(1):105-111. PubMed ID: 30447710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study.
    Schmitto JD; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Sood P; Damme L; Netuka I
    Eur J Heart Fail; 2019 Jan; 21(1):90-97. PubMed ID: 30052304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [ANMCO Position paper: Care pathway for advanced heart failure patients candidate for heart transplantation/ventricular assist device].
    Iacoviello M; Cipriani M; Valente S; Marini M; Ammirati E; Benvenuto M; Cassaniti LR; De Maria R; Gori M; Municinò A; Navazio A; Amodeo V; Aspromonte N; Barili F; Casolo G; Clemenza F; Di Eusanio M; Di Lenarda A; Di Tano G; Domenicucci S; Faggian G; Francese GM; Frongillo D; Gilardi R; Iacovoni A; Imazio M; Livi U; Maiello C; Milano A; Mondino M; Moreo AM; Mortara A; Murrone A; Palmieri V; Pelenghi S; Pini D; Pistono M; Porcu M; Potena L; Rinaldi M; Romanò M; Roncon L; Rossini R; Russo CF; Scotto di Uccio F; Urbinati S; Zecchin M; Caldarola P; Oliveti A; Frigerio M; Musumeci F; Gulizia MM; Oliva F; Gabrielli D; Colivicchi F
    G Ital Cardiol (Rome); 2022 May; 23(5):340-378. PubMed ID: 35578958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure.
    Hashim T; Sanam K; Revilla-Martinez M; Morgan CJ; Tallaj JA; Pamboukian SV; Loyaga-Rendon RY; George JF; Acharya D
    Circ Heart Fail; 2015 Sep; 8(5):880-6. PubMed ID: 26179184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the ventricular assist device programme in the UK.
    Sharples L; Buxton M; Caine N; Cafferty F; Demiris N; Dyer M; Freeman C
    Health Technol Assess; 2006 Nov; 10(48):1-119, iii-iv. PubMed ID: 17134596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should cardiac resynchronization therapy be a rescue therapy for inotrope-dependent patients with advanced heart failure?
    Imamura T; Kinugawa K; Nitta D; Hatano M; Komuro I
    J Card Fail; 2015 Jun; 21(6):535-8. PubMed ID: 25930086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-State Understanding and Experience of Patients Receiving Continuous Intravenous Inotropic Support as Palliative Therapy: A Multicenter Survey.
    Maini M; Anderson KM; Seplowe M; Crowell NA; Pitcher C; Scally R; Weintraub WS; Najjar SS; Groninger H; Rao A
    J Palliat Med; 2024 Aug; 27(8):1026-1032. PubMed ID: 38564223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.